GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated November 15, 2022, reports on the status of two employee share schemes for the six-month period from May 1, 2022, to October 31, 2022. The filing serves as a Block Listing Six Monthly Return required under UK Listing Rules.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It exclusively details the movement of unallotted securities under specific equity incentive plans.
- GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan:
- Opening balance of unallotted securities: 44,219
- Securities issued/allotted during period: 0
- Closing balance of unallotted securities: 44,219
- GlaxoSmithKline plc Share Save Plan 2012:
- Opening balance of unallotted securities: 1,373,495
- Securities issued/allotted during period: 251,620
- Closing balance of unallotted securities: 1,121,875
Material Changes
The primary material change reported is the allotment of 251,620 securities under the Share Save Plan 2012, reducing the available pool for that scheme. No changes were recorded for the Deferred Annual Bonus Plan during this period.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risk factors, or contingencies. It is a statutory disclosure regarding share scheme administration.
Key Facts for Investor Verification
- Verify the total number of shares issued under the Share Save Plan 2012 (251,620) against the company's broader capitalization table.
- Confirm the remaining pool of unallotted shares for future employee incentives (1,121,875 for Share Save Plan; 44,219 for Deferred Bonus Plan).
- Note that this filing does not reflect the company's operational or financial performance for the period.